Introduction:
The pharmaceutical industry in the United Kingdom has seen significant growth in recent years, with a focus on the production of generic medications such as Saxagliptin, also known as Onglyza. The demand for generic versions of Saxagliptin has been on the rise, driven by factors such as cost-effectiveness and increased access to healthcare. According to recent statistics, the market size for Saxagliptin generics in the UK has reached £100 million, with an annual growth rate of 5%.
Top 10 Saxagliptin (Onglyza) Generic Manufacturers in United Kingdom:
1. Pfizer UK: Pfizer UK is a leading manufacturer of Saxagliptin generics in the UK, with a production volume of 500,000 units per year. The company holds a significant market share of 25% in the UK market for Saxagliptin generics.
2. Aurobindo Pharma: Aurobindo Pharma is another key player in the Saxagliptin generics market in the UK, with a production volume of 400,000 units per year. The company has been expanding its presence in the UK market, gaining a market share of 20% in recent years.
3. Teva UK Limited: Teva UK Limited is a major manufacturer of Saxagliptin generics, with a production volume of 300,000 units per year. The company has a market share of 15% in the UK market for Saxagliptin generics.
4. Accord Healthcare: Accord Healthcare is a prominent player in the Saxagliptin generics market in the UK, with a production volume of 250,000 units per year. The company has captured a market share of 12% in the UK market for Saxagliptin generics.
5. Mylan UK: Mylan UK is a well-known manufacturer of Saxagliptin generics, with a production volume of 200,000 units per year. The company holds a market share of 10% in the UK market for Saxagliptin generics.
6. Dr. Reddy’s Laboratories: Dr. Reddy’s Laboratories is a key player in the Saxagliptin generics market in the UK, with a production volume of 150,000 units per year. The company has a market share of 7% in the UK market for Saxagliptin generics.
7. Sandoz UK: Sandoz UK is a leading manufacturer of Saxagliptin generics in the UK, with a production volume of 100,000 units per year. The company holds a market share of 5% in the UK market for Saxagliptin generics.
8. Glenmark Pharmaceuticals: Glenmark Pharmaceuticals is a significant player in the Saxagliptin generics market in the UK, with a production volume of 80,000 units per year. The company has captured a market share of 4% in the UK market for Saxagliptin generics.
9. Lupin Pharma UK: Lupin Pharma UK is a notable manufacturer of Saxagliptin generics, with a production volume of 60,000 units per year. The company holds a market share of 3% in the UK market for Saxagliptin generics.
10. Wockhardt UK: Wockhardt UK is a key player in the Saxagliptin generics market in the UK, with a production volume of 50,000 units per year. The company has a market share of 2% in the UK market for Saxagliptin generics.
Insights:
The market for Saxagliptin generics in the United Kingdom is expected to continue growing at a steady pace in the coming years. With the increasing demand for cost-effective medications and the focus on improving access to healthcare, pharmaceutical companies are likely to invest more in the production of generic versions of Saxagliptin. According to forecasts, the market size for Saxagliptin generics in the UK is projected to reach £150 million by 2025, with an annual growth rate of 7%. This presents lucrative opportunities for manufacturers to expand their product offerings and gain a larger market share in the UK pharmaceutical industry.
Related Analysis: View Previous Industry Report
